Daiwa Securities Group’s Zai Lab ZLAB Stock Holding History

Daiwa Securities Group’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,400	Closed	-$4.83K	–	1264
2026 Q1	$4.83K	Buy	+5,400	New	+$100K	﹤0.01%	1156

Other funds holding ZLAB

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Daiwa Securities Group's ZLAB Position: Q2 2026 in Review

Daiwa Securities Group sold out of Zai Lab (ZLAB) in Q2 2026, closing a stake of 5,400 shares — an estimated $102K sold.

Daiwa Securities Group first reported a position in ZLAB in Q4 2018 and held it in 30 quarters. The position peaked at $400K in Q1 2025. 92 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

Daiwa Securities Group reported no remaining Zai Lab position as of Q2 2026 after selling out during the quarter.
Daiwa Securities Group sold 5,400 Zai Lab shares in Q2 2026, an estimated $102K.
Daiwa Securities Group first reported a position in Zai Lab in Q4 2018 and held it in 30 quarters.
Daiwa Securities Group's Zai Lab position peaked at $400K in Q1 2025.
92 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.